Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 1 news story.

Let’s put this one under the “This is why you run clinical trials” heading. A have looked at inhibitors of indoleamine 2,3…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.